CMS certification 240010
Mayo Clinic Hospital Rochester
1216 Second Street Southwest, Rochester, MN 55902
Mayo Clinic Hospital Rochester has a CMS overall rating of 5 out of 5 stars. 89% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 16 and worse on none. Emergency patients spend a median of 4 h 6 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 4,221 completed surveys, 39% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MN | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 611 visits sampled · US median for EDs of the same volume: 3 h 21 min | 4 h 6 min | 2 h 11 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 33 visits sampled | 5 h 27 min | 3 h 24 min | 4 h 17 min |
| Left before being seen Lower is better · 84,799 patients | 3% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 19 patients | 58% | 73% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 145 patients | 42% | 58% | 65% |
How Mayo Clinic Hospital Rochester compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Mayo Clinic Hospital RochesterThis hospital | 5/5 | 89% | 4 h 6 min | 16 better |
| Olmsted Medical CenterSame city | 4/5 | 78% | 2 h 15 min | 1 better |
| St Elizabeth Medical CenterSame ZIP area · Wabasha | Not rated | 74% | 1 h 35 min | No different |
| Winona Health ServicesSame ZIP area · Winona | 2/5 | 64% | 2 h 22 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Rochester.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 11,199 cases | Too few cases | 1.9% | 3.9% |
| Heart attack 523 cases | Too few cases | 8.6% | 11.9% |
| Heart failure 1,187 cases | Too few cases | 8.3% | 11.1% |
| Pneumonia 896 cases | Too few cases | 10.1% | 15.2% |
| Stroke 674 cases | Too few cases | 9.5% | 11.9% |
| COPD 253 cases | Too few cases | 6.9% | 8.6% |
| Heart bypass surgery (CABG) 324 cases | Too few cases | 2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Better | 0.77 likely 0.65 – 0.88 | 1 |
| After hip or knee replacement 244 cases | Too few cases | 4.5% | 4.1% |
| Deaths after a serious but treatable surgical complication 726 cases | Better | 141.37 per 1,000 likely 117.06 per 1,000 – 165.67 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 22,863 cases | Better | 0.24 per 1,000 likely 0 per 1,000 – 0.51 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 24,982 cases | No different | 0.2 per 1,000 likely 0.06 per 1,000 – 0.33 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 28,469 cases | No different | 0.21 per 1,000 likely 0.07 per 1,000 – 0.34 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 11,424 cases | Worse | 3.63 per 1,000 likely 2.91 per 1,000 – 4.34 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 9,136 cases | No different | 1.91 per 1,000 likely 1.36 per 1,000 – 2.45 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 8,646 cases | Better | 5.26 per 1,000 likely 3.63 per 1,000 – 6.9 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 13,578 cases | No different | 4.19 per 1,000 likely 3.33 per 1,000 – 5.05 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 8,764 cases | Better | 3.69 per 1,000 likely 2.51 per 1,000 – 4.86 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 3,855 cases | Worse | 2.77 per 1,000 likely 1.83 per 1,000 – 3.71 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 8,643 cases | No different | 0.75 per 1,000 likely 0.28 per 1,000 – 1.22 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.42 likely 0.29 – 0.58 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.63 likely 0.47 – 0.83 | 1 |
| Surgical site infections after colon surgery | No different | 0.72 likely 0.49 – 1.03 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.08 likely 0.34 – 2.6 | 1 |
| MRSA bloodstream infections | Better | 0.15 likely 0.05 – 0.37 | 1 |
| C. diff intestinal infections | Better | 0.56 likely 0.48 – 0.65 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 758 cases | Too few cases | 13.3% | 14.4% |
| Readmitted after heart failure 1,588 cases | Too few cases | 19.8% | 21.3% |
| Readmitted after pneumonia 1,256 cases | Too few cases | 16.9% | 17.3% |
| Readmitted after COPD 394 cases | Too few cases | 20.2% | 20% |
| Readmitted after heart bypass surgery 347 cases | Too few cases | 10.8% | 11% |
| Readmitted after hip or knee replacement 225 cases | Too few cases | 6.8% | 5.8% |
| Days back in hospital after a heart attack 584 cases | Too few cases | -15.6 days per 100 | — |
| Days back in hospital after heart failure 1,334 cases | Too few cases | 2.4 days per 100 | — |
| Days back in hospital after pneumonia 943 cases | Too few cases | -10.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 5,586 cases | No different | 14.9 per 1,000 likely 12.5 per 1,000 – 17.7 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 562 cases | No different | 12.6 per 100 likely 10.1 per 100 – 15.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 562 cases | No different | 5.8 per 100 likely 4.3 per 100 – 7.8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 4,767 cases | No different | 0.9 likely 0.8 – 1 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $5M
- 2020 $6.3M
- 2021 $6.1M
- 2022 $6.8M
- 2023 $10M
- 2024 $9.7M
- 2025 $9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $450,549 | 12 |
| Space rental and facility fees | $244,825 | 48 |
| Grants | $150,289 | 20 |
| Education | $18,838 | 5 |
| Royalties and licensing fees | $5,297 | 2 |
| Speaking, teaching and other services | $3,251 | 2 |
| Food and beverage | $293 | 2 |
| Debt forgiveness | $25 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Philips North America LLC | $1.9M | 5 |
| Pfizer INC. | $948,198 | 32 |
| Siemens Medical Solutions USA, Inc. | $916,401 | 20 |
| Takeda Pharmaceuticals U.S.A., Inc. | $910,391 | 144 |
| Abbvie INC. | $881,706 | 4 |
| Kiniksa Pharmaceuticals International, plc | $718,274 | 8 |
| Intuitive Surgical, INC. | $391,219 | 14 |
| E.R. Squibb & Sons, L.L.C. | $361,650 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| WF-011389: Cutting Edge Cardiac MRI Develoment in a Clinical Environment Philips North America LLC | $1.5M |
| A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in BRCA wild-type, folate receptor alpha (FR)-positive recurrent ovarian cancer e… ABBVIE INC. | $881,706 |
| KPL Kiniksa Pharmaceuticals International, plc | $646,117 |
| AN OPENLABEL RANDOMIZED PHASE 3 STUDY OF TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND MFOLFOX6 VERSUS MFOLFOX6 GIVEN WITH OR WITHOUT EITHER CETUXIMA… PFIZER INC. | $493,071 |
| WF-011317: Clinical and Research Partnership with Mayo Clinic Philips North America LLC | $360,250 |
| MRZ-108 Phase 1, Multicenter, Open-label, Dose-escalation, Combination Study of MRZ & Bevacizumab in Bevacizumab-Nave Subjects with WHO Grade IV Mali… E.R. Squibb & Sons, L.L.C. | $300,000 |
| A SINGLE ARM OPEN LABEL PHASE 2 STUDY OF TUCATINIB IN COMBINATION WITH TRASTUZUMAB DERUXTECAN IN SUBJECTS WITH PREVIOUSLY TREATED UNRESECTABLE LOCALL… PFIZER INC. | $263,862 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TAK-101 FOR THE PREVENTION OF GLUTE… Takeda Pharmaceuticals U.S.A., Inc. · NCT04530123 | $245,240 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Mayo Clinic Hospital Rochester
Is Mayo Clinic Hospital Rochester a good hospital?
Mayo Clinic Hospital Rochester has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 16 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Mayo Clinic Hospital Rochester?
89% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 4,221 completed HCAHPS surveys.
How long is the wait in the Mayo Clinic Hospital Rochester emergency room?
Emergency patients spend a median of 4 h 6 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Mayo Clinic Hospital Rochester receive money from drug and device companies?
Drug and device makers reported $9M in payments to Mayo Clinic Hospital Rochester for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.